Overview

Sarilumab in Patients With Glucocorticoid-Dependent Sarcoidosis

Status:
Recruiting
Trial end date:
2027-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness and the safety of sarilumab in patients with glucocorticoid-dependent sarcoidosis.
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Treatments:
Glucocorticoids